We are grateful to The Leon Lowenstein Foundation for their leadership support in the creation of RockEDU Online.
Financial Support and Community Partnerships from the following entities were instrumental in the creation of content hosted on this site:
- The Dreyfus Foundation
- Math for America (MfA)
- New York City Department of Education Research Pathways Program
- Laboratories and Scientists participating in Science Saturday, including from The Rockefeller University, Memorial Sloan Kettering Cancer Center (MSKCC), Weill Cornell Medical School, Hunter College, and more…
We live in a global society, where travel is the norm. Over the past few months, most of the world has been adhering to some degree of social distancing measures. Despite the fact that we have not yet identified a vaccine or therapeutic for COVID-19, many locations are beginning to reopen. This reality requires that we remain vigilant and on the lookout for future COVID-19 outbreaks. For our last D4P webinar of the academic year, our D4P fellows Devany West and Anna Kolstad will take us through “Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts,” published in the Lancet Global Health journal in February of 2020. Here, we will discuss insights into a model that takes into consideration contact tracing efforts and case isolation to help contain the spread of a nascent COVID-19 outbreak. ... See MoreSee Less
Great presenters and discussion! Thank you!
Great presentation! Thank you for all the time and effort put into this serie.
Check out Chloe and Sinead's talk here: rockedu.rockefeller.edu/d4p/d4p-modeling-math-and-social-mixing/
Now is a great time to start dropping questions in the chat box! Leave your questions here and we'll bring them to our speakers!
Hello all and welcome to our last d4p of the 2019-2020 school year! Where are you tuning in from today?
Don’t forget to leave your questions for our speakers, here!
Please take our d4p survey: www.surveymonkey.com/r/CDRC7BP
Check out our archived talks! Please take our d4p survey: www.surveymonkey.com/r/CDRC7BP
Join us for our LAST Data for the People of the 2019-2020 school year!
Register here: rocku.zoom.us/webinar/register/WN_pxuR9-fZQTuwY2QfAzI0cw
TOMORROW - Wednesday, June 17th at 3:30pm ET.
We live in a global society, where travel is the norm. While most of the world has been observing social distancing measures in some form, many locations are beginning to open up, despite having no accessible vaccine or other therapeutic for treating COVID-19. Until these measures can be implemented, we must be on the lookout for future COVID-19 outbreaks. For our last D4P webinar of the academic year, our D4P fellows Devany West and Anna Kolstad will take us through “Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts,” published in the Lancet Global Health journal in February of 2020. Here, we will discuss insights into a model that takes into consideration both contact tracing efforts and case isolation to help contain the spread of a nascent COVID-19 outbreak.
Anna Kolstad is a research assistant at the Icahn School of Medicine at Mount Sinai. She has a background in engineering and a fascination with the nervous system. In her current laboratory she is using new imaging techniques to study structural and anatomical organization of the brain. She is often astounded by the beauty and complexity of the structures she sees! Outside of the lab Anna loves reading novels, traveling, and spending time in the outdoors.
Devany West is a graduate fellow at The Rockefeller University where she specializes in Biophysics research. Outside of science, Devany enjoys participating in dance classes that range in genre from ballet to hip-hop. She also loves playing music, writing fiction and seeing live shows!
Data for the People (D4P) is a weekly, interactive web-series that invites ‘the people’ (all of our community members, worldwide!) to engage with relevant scientific research topics. Scientific research topics are presented by scientists in our communities—directly from the primary scientific literature— and explored in a way that maintains the rigor of the research, while eliminating the inaccessible jargon. ... See MoreSee Less
Check out our newest Scientist of New York...Nneoma Adaku (@travelingnomes)! Nneoma is an MD-PhD Student in the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program where she studies Cancer Biology. Check out the full interview, below, to learn about Nneoma’s passion for science and medicine, advice for aspiring scientists and passions outside of research (hint: this includes visiting museums, biking and traveling, to name a few!)
Know someone who may be interested in being featured on our blog? Reach out!
#sciony #biology #bio #science #scientist #scientists #stem #research #research #experiment #medicine #nyc ... See MoreSee Less
There is a huge spectrum of symptom presentation in people with COVID-19. While some people remain asymptomatic, there are several known pre-existing conditions (comorbidities) that correlate with increased disease severity. In this D4P presentation, scientist Viktor Belay will present data from “Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes,” published April 30, 2020. The authors in this report set out to better understand the impact of COVID-19 in patients with type 2 diabetes through a retrospective study on affected patients in Hubei Province, China. ... See MoreSee Less
I believe diabetes goal is to get diabetics HbA1c <8. The study indicated >10 as uncontrolled group. I’m wondering if more stringent HbA1c levels would increase or decrease the death rate...What do you think?
Good job, presenter!
Great talk today- really enjoyed. Thank you
Given that a p-value represents the probability that a phenomenon happens by chance, what p-vale would we expect from a sig test of something that is most probably NOT random?
Hi All! Did the paper mention the use of ACE inhibitors/ ARB medications. (which are often given to Diabetic patients to treat hypertension) There was talk early on about ARBs
Have to go now. But this has been great and all the best with future research on this!
Really good presentation. Presenter is very clear!
Hello, and welcome to Data for the People!
Please share your questions, here, for our d4p presenter, Viktor!
Thank you, Victor!
Could there be comorbidities (like cardiovascular disease), demographics (age), or concomitant medications that affected the outcomes?
a) .9, b) .001, c) 1, d) .67
Keeping sending your questions!
Hello.. joining in
The answer is B!
Register for next week (AKA our LAST d4p of the 2019-2020 school year!) rocku.zoom.us/webinar/register/WN_pxuR9-fZQTuwY2QfAzI0cw
Please take our survey: www.surveymonkey.com/r/NDKRLBZ
Breaking down barriers between the science world and the rest of society requires a thoughtful approach and inspirational leadership. And sometimes, dancing on the internet.
Don't miss this interview with @rockedu_ director @JeanneGarb in #SeekMagazine:
Science takes a village! Thank you to @FactsMachinePod crew @SweaterVestSci @_emcosta @ArksAndSciences for hanging with our #SSRPv2020 students today for some trivia. Can't wait for the next round! @RockEDU_ #sciencetakesavillage
You can also check out @rockedu_'s Guide to Inclusive Outreach, which includes mentoring handbook, summary and recommendations for science outreach (via #sciout18 conference), and other good stuff. More coming! https://t.co/ViSieTdok6
Scientists in the lab of the late Paul Greengard have used advanced technology to “micro-dissect” the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets. #RockefellerScience
Meet our new SCIONY, @simonedsaid! Simón(e) is a @nyuniversity Doctoral Candidate where she studies #Neuroscience. Read the post to learn about Simón(e)’s passion for exploring unknowns, her view on the utility of good mentorship + her creative pursuits! https://t.co/5oBNLFWkXF